Companies:
10,785
total market cap:
$133.781 T
Sign In
๐บ๐ธ
EN
English
$ USD
โฌ
EUR
๐ช๐บ
โน
INR
๐ฎ๐ณ
ยฃ
GBP
๐ฌ๐ง
$
CAD
๐จ๐ฆ
$
AUD
๐ฆ๐บ
$
NZD
๐ณ๐ฟ
$
HKD
๐ญ๐ฐ
$
SGD
๐ธ๐ฌ
Global ranking
Ranking by countries
America
๐บ๐ธ United States
๐จ๐ฆ Canada
๐ฒ๐ฝ Mexico
๐ง๐ท Brazil
๐จ๐ฑ Chile
Europe
๐ช๐บ European Union
๐ฉ๐ช Germany
๐ฌ๐ง United Kingdom
๐ซ๐ท France
๐ช๐ธ Spain
๐ณ๐ฑ Netherlands
๐ธ๐ช Sweden
๐ฎ๐น Italy
๐จ๐ญ Switzerland
๐ต๐ฑ Poland
๐ซ๐ฎ Finland
Asia
๐จ๐ณ China
๐ฏ๐ต Japan
๐ฐ๐ท South Korea
๐ญ๐ฐ Hong Kong
๐ธ๐ฌ Singapore
๐ฎ๐ฉ Indonesia
๐ฎ๐ณ India
๐ฒ๐พ Malaysia
๐น๐ผ Taiwan
๐น๐ญ Thailand
๐ป๐ณ Vietnam
Others
๐ฆ๐บ Australia
๐ณ๐ฟ New Zealand
๐ฎ๐ฑ Israel
๐ธ๐ฆ Saudi Arabia
๐น๐ท Turkey
๐ท๐บ Russia
๐ฟ๐ฆ South Africa
>> All Countries
Ranking by categories
๐ All assets by Market Cap
๐ Automakers
โ๏ธ Airlines
๐ซ Airports
โ๏ธ Aircraft manufacturers
๐ฆ Banks
๐จ Hotels
๐ Pharmaceuticals
๐ E-Commerce
โ๏ธ Healthcare
๐ฆ Courier services
๐ฐ Media/Press
๐ท Alcoholic beverages
๐ฅค Beverages
๐ Clothing
โ๏ธ Mining
๐ Railways
๐ฆ Insurance
๐ Real estate
โ Ports
๐ผ Professional services
๐ด Food
๐ Restaurant chains
โ๐ป Software
๐ Semiconductors
๐ฌ Tobacco
๐ณ Financial services
๐ข Oil&Gas
๐ Electricity
๐งช Chemicals
๐ฐ Investment
๐ก Telecommunication
๐๏ธ Retail
๐ฅ๏ธ Internet
๐ Construction
๐ฎ Video Game
๐ป Tech
๐ฆพ AI
>> All Categories
ETFs
๐ All ETFs
๐๏ธ Bond ETFs
๏ผ Dividend ETFs
โฟ Bitcoin ETFs
โข Ethereum ETFs
๐ช Crypto Currency ETFs
๐ฅ Gold ETFs & ETCs
๐ฅ Silver ETFs & ETCs
๐ข๏ธ Oil ETFs & ETCs
๐ฝ Commodities ETFs & ETNs
๐ Emerging Markets ETFs
๐ Small-Cap ETFs
๐ Low volatility ETFs
๐ Inverse/Bear ETFs
โฌ๏ธ Leveraged ETFs
๐ Global/World ETFs
๐บ๐ธ USA ETFs
๐บ๐ธ S&P 500 ETFs
๐บ๐ธ Dow Jones ETFs
๐ช๐บ Europe ETFs
๐จ๐ณ China ETFs
๐ฏ๐ต Japan ETFs
๐ฎ๐ณ India ETFs
๐ฌ๐ง UK ETFs
๐ฉ๐ช Germany ETFs
๐ซ๐ท France ETFs
โ๏ธ Mining ETFs
โ๏ธ Gold Mining ETFs
โ๏ธ Silver Mining ETFs
๐งฌ Biotech ETFs
๐ฉโ๐ป Tech ETFs
๐ Real Estate ETFs
โ๏ธ Healthcare ETFs
โก Energy ETFs
๐ Renewable Energy ETFs
๐ก๏ธ Insurance ETFs
๐ฐ Water ETFs
๐ด Food & Beverage ETFs
๐ฑ Socially Responsible ETFs
๐ฃ๏ธ Infrastructure ETFs
๐ก Innovation ETFs
๐ Semiconductors ETFs
๐ Aerospace & Defense ETFs
๐ Cybersecurity ETFs
๐ฆพ Artificial Intelligence ETFs
Watchlist
Account
Photronics
PLAB
#4390
Rank
$2.38 B
Marketcap
๐บ๐ธ
United States
Country
$40.41
Share price
9.28%
Change (1 day)
94.65%
Change (1 year)
๐ Semiconductors
๐ฉโ๐ป Tech
Categories
Market cap
Revenue
Earnings
Price history
P/E ratio
P/S ratio
More
Price history
P/E ratio
P/S ratio
P/B ratio
Operating margin
EPS
Stock Splits
Shares outstanding
Fails to deliver
Cost to borrow
Total assets
Total liabilities
Total debt
Cash on Hand
Net Assets
Annual Reports (10-K)
Photronics
Quarterly Reports (10-Q)
Financial Year FY2015 Q3
Photronics - 10-Q quarterly report FY2015 Q3
Text size:
Small
Medium
Large
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended August 2, 2015
OR
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ___ to ___
Commission file number 0-15451
PHOTRONICS, INC.
(Exact name of registrant as specified in its charter)
Connecticut
06-0854886
(State or other jurisdiction of incorporation or organization)
(IRS Employer Identification No.)
15 Secor Road, Brookfield, Connecticut
06804
(Address of principal executive offices)
(Zip Code)
Registrant's telephone number, including area code
(203) 775-9000
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter periods that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes
☒
No
☐
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes
☒
No
☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer," "accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
Large Accelerated Filer
☐
Accelerated Filer
☒
Non-Accelerated Filer
☐
Smaller Reporting Company
☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes
☐
No
☒
Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.
Class
Outstanding at September 1, 2015
Common Stock, $0.01 par value
66,768,764 Shares
Forward-Looking Statements
The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements made by or on behalf of Photronics, Inc. ("Photronics" or "the Company" or “we”). These statements are based on management's beliefs, as well as assumptions made by, and information currently available to, management. Forward-looking statements may be identified by words like "expect," "anticipate," "believe," "plan," "projects," “could,” “estimate,” “intend,” “may,” “will” and similar expressions, or the negative of such terms, or other comparable terminology. All forward-looking statements involve risks and uncertainties that are difficult to predict. In particular, any statement contained in this quarterly report on Form 10-Q or in other documents filed with the Securities and Exchange Commission, in press releases or in the Company's communications and discussions with investors and analysts in the normal course of business through meetings, phone calls, or conference calls regarding, among other things, the consummation and benefits of transactions and acquisitions, expectations with respect to future sales, financial performance, operating efficiencies, or product expansion, are subject to known and unknown risks, uncertainties, and contingencies, many of which are beyond the control of the Company. Various factors may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements expressed or implied by forward-looking statements. Factors that might affect forward-looking statements include, but are not limited to, overall economic and business conditions; economic and political conditions in international markets; the demand for the Company's products; competitive factors in the industries and geographic markets in which the Company competes; federal, state and international tax requirements (including tax rate changes, new tax laws and revised tax law interpretations); interest rate and other capital market conditions, including changes in the market price of the Company's securities; foreign currency exchange rate fluctuations; changes in technology; the timing, impact, and other uncertainties relating to transactions and acquisitions, divestitures and joint ventures as well as decisions the Company may make in the future regarding the Company’s business, capital and organizational structure and other matters; the seasonal and cyclical nature of the semiconductor and flat panel display industries; management changes; damage or destruction to the Company's facilities, or the facilities of its customers or suppliers, by natural disasters, labor strikes, political unrest, or terrorist activity; the ability of the Company to (i) place new equipment in service on a timely basis; (ii) obtain additional financing; (iii) achieve anticipated synergies and cost savings; (iv) fully utilize its tools; (v) achieve desired yields, pricing, product mix, and market acceptance of its products and (vi) obtain necessary export licenses. Any forward-looking statements should be considered in light of these factors. Accordingly, there is no assurance that the Company's expectations will be realized. The Company does not assume responsibility for the accuracy and completeness of the forward-looking statements and does not assume an obligation to provide revisions to any forward-looking statements, except as otherwise required by securities and other applicable laws.
2
PHOTRONICS, INC.
AND SUBSIDIARIES
INDEX
PART I.
FINANCIAL INFORMATION
Page
Item 1.
Condensed Consolidated Financial Statements
4
Condensed Consolidated Balance Sheets at August 2, 2015 and November 2, 2014
4
Condensed Consolidated Statements of Income for the Three and Nine Months Ended August 2, 2015 and August 3, 2014
5
Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three and Nine Months Ended August 2, 2015 and August 3, 2014
6
Condensed Consolidated Statements of Cash Flows for the Nine Months Ended August 2, 2015 and August 3, 2014
7
Notes to Condensed Consolidated Financial Statements
8
Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
20
Item 3.
Quantitative and Qualitative Disclosures about Market Risk
25
Item 4.
Controls and Procedures
26
PART II.
OTHER INFORMATION
Item 1A.
Risk Factors
26
Item 6.
Exhibits
27
3
Index
PART I.
FINANCIAL INFORMATION
Item 1.
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
PHOTRONICS, INC. AND SUBSIDIARIES
Condensed Consolidated
Balance Sheets
(in thousands, except per share amounts)
(unaudited)
August 2,
2015
November 2,
2014
ASSETS
Current assets:
Cash and cash equivalents
$
191,562
$
192,929
Accounts receivable, net of allowance of $3,375 in 2015 and $3,078 in 2014
104,701
94,515
Inventories
23,266
22,478
Other current assets
21,037
26,570
Total current assets
340,566
336,492
Property, plant and equipment, net
568,921
550,069
Investment in joint venture
93,040
93,122
Intangible assets, net
26,280
30,294
Deferred income taxes
11,801
11,036
Other assets
5,483
8,170
Total assets
$
1,046,091
$
1,029,183
LIABILITIES AND EQUITY
Current liabilities:
Current portion of long-term borrowings
$
16,577
$
10,381
Accounts payable
110,945
86,495
Accrued liabilities
34,014
42,241
Total current liabilities
161,536
139,117
Long-term borrowings
118,457
131,805
Other liabilities
20,051
18,767
Total liabilities
300,044
289,689
Commitments and contingencies
Equity:
Preferred stock, $0.01 par value, 2,000 shares authorized, none issued and outstanding
-
-
Common stock, $0.01 par value, 150,000 shares authorized, 66,507 shares issued and outstanding at August 2, 2015 and 65,930 shares issued and outstanding at November 2, 2014
665
659
Additional paid-in capital
524,924
520,182
Retained earnings
111,438
85,435
Accumulated other comprehensive income (loss)
(8,256
)
21,774
Total Photronics, Inc. shareholders' equity
628,771
628,050
Noncontrolling interests
117,276
111,444
Total equity
746,047
739,494
Total liabilities and equity
$
1,046,091
$
1,029,183
See accompanying notes to condensed consolidated financial statements.
4
Index
PHOTRONICS, INC. AND SUBSIDIARIES
Condensed Consolidated
Statements of Income
(in thousands, except per share amounts)
(unaudited)
Three Months Ended
Nine Months Ended
August 2,
2015
August 3,
2014
August 2,
2015
August 3,
2014
Net sales
$
131,699
$
124,852
$
382,513
$
331,276
Costs and expenses:
Cost of sales
(94,456
)
(96,202
)
(283,991
)
(257,554
)
Selling, general and administrative
(12,430
)
(12,394
)
(36,795
)
(38,092
)
Research and development
(6,253
)
(5,199
)
(16,743
)
(16,111
)
Operating income
18,560
11,057
44,984
19,519
Other income (expense):
Gain on acquisition
-
-
-
16,372
Interest expense
(1,209
)
(1,809
)
(3,812
)
(5,610
)
Interest and other income (expense), net
1,449
641
1,312
2,346
Income before income tax provision
18,800
9,889
42,484
32,627
Income tax provision
(3,390
)
(2,545
)
(7,775
)
(7,291
)
Net income
15,410
7,344
34,709
25,336
Net income attributable to noncontrolling interests
(3,304
)
(3,158
)
(8,706
)
(3,617
)
Net income attributable to Photronics, Inc. shareholders
$
12,106
$
4,186
$
26,003
$
21,719
Earnings per share:
Basic
$
0.18
$
0.07
$
0.39
$
0.35
Diluted
$
0.17
$
0.07
$
0.37
$
0.34
Weighted-average number of common shares outstanding:
Basic
66,454
61,436
66,250
61,336
Diluted
78,569
62,432
78,300
77,706
See accompanying notes to condensed consolidated financial statements.
5
Index
PHOTRONICS, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of
Comprehensive Income (Loss)
(in thousands)
(unaudited)
Three Months Ended
Nine Months Ended
August 2,
2015
August 3,
2014
August 2,
2015
August 3,
2014
Net income
$
15,410
$
7,344
$
34,709
$
25,336
Other comprehensive income (loss), net of tax of $0:
Foreign currency translation adjustments
(25,326
)
2,088
(32,894
)
5,194
Amortization of cash flow hedge
32
32
96
96
Total other comprehensive income (loss)
(25,294
)
2,120
(32,798
)
5,290
Comprehensive income (loss)
(9,884
)
9,464
1,911
30,626
Less: comprehensive income attributable to noncontrolling interests
1,105
3,703
5,939
4,116
Comprehensive income (loss) attributable to Photronics, Inc. shareholders
$
(10,989
)
$
5,761
$
(4,028
)
$
26,510
See accompanying notes to condensed consolidated financial statements.
6
Index
PHOTRONICS, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of
Cash Flows
(in thousands)
(unaudited)
Nine Months Ended
August 2,
2015
August 3,
2014
Cash flows from operating activities:
Net income
$
34,709
$
25,336
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
61,465
58,412
Gain on acquisition
-
(16,372
)
Changes in assets and liabilities:
Accounts receivable
(13,744
)
(1,479
)
Inventories
(1,814
)
(3,339
)
Other current assets
1,496
1,657
Accounts payable, accrued liabilities and other
9,715
(2,377
)
Net cash provided by operating activities
91,827
61,838
Cash flows from investing activities:
Purchases of property, plant and equipment
(80,107
)
(58,278
)
Cash from acquisition
-
4,508
Other
(283
)
(759
)
Net cash used in investing activities
(80,390
)
(54,529
)
Cash flows from financing activities:
Repayments of long-term borrowings
(7,152
)
(27,432
)
Payments of deferred financing fees
-
(336
)
Proceeds from share-based arrangements
2,375
1,043
Other
(171
)
(597
)
Net cash used in financing activities
(4,948
)
(27,322
)
Effect of exchange rate changes on cash and cash equivalents
(7,856
)
736
Net decrease in cash and cash equivalents
(1,367
)
(19,277
)
Cash and cash equivalents at beginning of period
192,929
215,615
Cash and cash equivalents at end of period
$
191,562
$
196,338
Supplemental disclosure of noncash information:
Accrual for property, plant and equipment purchased during the period
$
40,632
$
30,795
Noncash net assets from acquisition
-
110,211
See accompanying notes to condensed consolidated financial statements
.
7
Index
PHOTRONICS, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
Three Months and Nine Months Ended August 2, 2015 and August 3, 2014
(unaudited)
(in thousands, except share amounts)
NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION
Photronics, Inc. and its subsidiaries ("Photronics" or “the Company") is one of the world's leading manufacturers of photomasks, which are high precision photographic quartz plates containing microscopic images of electronic circuits. Photomasks are a key element in the manufacture of semiconductors and flat panel displays ("FPDs"), and are used as masters to transfer circuit patterns onto semiconductor wafers and flat panel substrates during the fabrication of integrated circuits ("ICs") and a variety of FPDs and, to a lesser extent, other types of electrical and optical components. The Company currently operates principally from nine manufacturing facilities, two of which are located in Europe, three in Taiwan, one in Korea, and three in the United States.
On April 4, 2014, DNP Photomask Technology Taiwan Co., Ltd. (“DPTT”), a wholly owned subsidiary of Dai Nippon Printing Co., Ltd. (“DNP”), merged into Photronics Semiconductor Mask Corporation (“PSMC”), a wholly owned subsidiary of Photronics. All of the assets and liabilities of DPTT existing prior to the merger were assumed by the renamed surviving entity of the merger, Photronics DNP Mask Corporation (“PDMC”). Photronics and DNP own 50.01 percent and 49.99 percent of PDMC, respectively.
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of management, adjustments, all of which are of a normal recurring nature, considered necessary for a fair presentation have been included. The Company is typically impacted during its first fiscal quarter by the North American and European holiday periods, as some customers reduce their effective workdays and orders during these periods. Additionally, the Company can be impacted during its first or second quarter by the Asian New Year holiday period, which may also reduce customer orders. Operating results for the interim period are not necessarily indicative of the results that may be expected for the fiscal year ending November 1, 2015. For further information, refer to the consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended November 2, 2014.
NOTE 2 – ACQUISITION OF DNP PHOTOMASK TECHNOLOGY TAIWAN CO., LTD.
On April 4, 2014, DPTT merged into PSMC, the Company’s IC manufacturing subsidiary located in Taiwan, to form PDMC. Throughout this report the merger of DPTT into PSMC is referred to as the “DPTT Acquisition.” In connection with the DPTT Acquisition, the Company transferred consideration with a fair value of $98.3 million. The Company owns 50.01 percent of PDMC and includes its financial results in its consolidated financial statements, while DNP owns the remaining 49.99 percent of PDMC. The Company also has the ability to appoint the majority of the directors of PDMC, including the chairman of its board of directors, select its management responsible for implementing its policies and procedures, and establish its operating and capital decisions and policies. Photronics determined it has control of PDMC by virtue of its tie-breaking voting rights within PDMC’s Board of Directors, thereby giving it the power to direct the activities of PDMC that most significantly impact its economic performance, including its decision making authority in the ordinary course of business. The DPTT Acquisition was the result of the Company’s desire to combine the strengths in logic and memory photomask technologies of PSMC and DPTT in order to enhance its capability with customers in the region.
The DPTT Acquisition met the conditions of a business combination as defined by Accounting Standards Codification (“ASC”) 805 and, as such, is accounted for under ASC 805 using the acquisition method of accounting. ASC 805 defines the three elements of a business as Input, Process and Output. As a result of the DPTT Acquisition, Photronics acquired the machinery and equipment utilized in the processes to manufacture product, the building that houses the entire operation and the processes needed to manufacture the product, all previously owned by DPTT. The former DPTT employees hired by Photronics in connection with the acquisition brought with them the skills, experience and know-how necessary to provide the operational processes that, when applied to the acquired assets, represent processes being applied to inputs to create outputs. Having met all three elements of a business as defined in ASC 805, the Company determined that the DPTT Acquisition should be accounted for as a business combination.
8
Index
The following table summarizes the fair values of assets acquired and liabilities assumed of DPTT, the fair value of the noncontrolling interests and consideration for DPTT at the acquisition date.
Cash and cash equivalents
$
4,508
Accounts receivable (gross amount of $28,560, of which $500 is estimated to be uncollectable)
28,060
Inventory
1,279
Deferred tax asset
9,787
Other current assets
11,517
Property, plant and equipment
95,431
Identifiable intangible assets
1,552
Other long-term assets
1,328
Accounts payable and accrued expenses
(32,410
)
Deferred tax liability
(3,042
)
Other long-term liabilities
(3,291
)
Total net assets acquired
114,719
Noncontrolling interests retained by DNP
57,348
57,371
Consideration – 49.99% of fair value of PSMC
40,999
Gain on acquisition
$
16,372
In addition to recording the fair values of the net assets acquired, the Company also recorded a gain on acquisition of $16.4 million in the three month period ended May 4, 2014, in accordance with ASC 805 using the acquisition method of accounting. The gain on acquisition was primarily due to the difference between the market values of the acquired real estate and personal property exceeding the fair value of the consideration transferred. In addition, a deferred tax liability of $3.0 million was recorded in the opening balance sheet, which had the effect of reducing the gain on acquisition to $16.4 million. Prior to recording the gain, the Company reassessed whether it had correctly identified all of the assets acquired and all of the liabilities assumed. Additionally, the Company also reviewed the procedures used to measure the amounts of the identifiable assets acquired, liabilities assumed and consideration transferred.
The fair value of the first component of consideration represents 49.99 percent of the fair value of PSMC, and is based on recent prices paid by the Company to acquire outstanding shares of PSMC (prior to the acquisition). As a result of the merger, the Company acquired the net assets of DPTT having a fair value of $114.7 million, less noncontrolling interests of $57.3 million retained by DNP, and transferred consideration with a fair value of $41.0 million, resulting in a gain of $16.4 million. The fair value of the total consideration transferred as of the acquisition date was $98.3 million, comprised of the 49.99% noncontrolling interest in DPTT of $57.3 million, and 49.99% of the fair value of PSMC of $41.0 million (112.9 million shares, or 49.99% of the outstanding common stock of PSMC).
We estimated the $114.7 million fair value of DPTT as of the acquisition date by applying an income approach as our valuation technique. Our income approach followed a discounted cash flow method, which applied our best estimates of future cash flows and an estimated terminal value discounted to present value at a rate of return taking into account the relative risk of the cash flows. To confirm the reasonableness of the value derived from the income approach, we also analyzed the values of comparable companies which are publicly traded. The acquisition date fair value of the property, plant and equipment of DPTT was $95.4 million, which was determined by utilizing the cost and, to a lesser extent, the market approach, based on an in-use premise of value. Inputs utilized by the Company to determine fair values of DPTT’s property, plant and equipment included a cost approach, which was adjusted for depreciation and condition for equipment, and adjusted for depreciation and local market conditions for real property. The noncontrolling interest of DPTT was calculated using the 49.99% of its total fair value of $114.7 million. The Company also used a market approach to corroborate the enterprise value of DPTT. This fair value measurement is based on significant inputs that are not observable in the market and thus represents a fair value measurement categorized within Level 3 of the fair value hierarchy. Key assumptions include local and current construction replacement cost multipliers, amounts of ancillary replacement costs, physical deterioration, and economic and functional obsolescence to adjust the current replacement costs by, as well as the estimated economic lives of the assets.
9
Index
Identifiable intangible assets acquired were primarily customer relationships, which represent the fair value of relationships and agreements DPTT had in place at the date of the merger. The customer relationships had a fair value of $1.5 million at the acquisition date, determined by using the multi-period excess earnings method, and are amortized over a twelve year estimated useful life. The acquisition date fair value of the remainder of the identifiable assets acquired and liabilities assumed were equivalent to, or did not materially differ from, their carrying values
Acquisition costs related to the merger were $2.5 million for the nine month period ended August 3, 2014, and are included in selling, general and administrative expense in the condensed consolidated statements of income.
NOTE 3 - CHANGES IN EQUITY
The following tables set forth the Company's consolidated changes in equity for the three and nine month periods ended August 2, 2015 and August 3, 2014:
Three Months Ended August 2, 2015
Photronics, Inc. Shareholders
Accumulated
Other
Comprehensive
Income (Loss)
Common Stock
Additional
Paid-in
Capital
Retained
Earnings
Non-
controlling
Interests
Total
Equity
Shares
Amount
Balance at May 3, 2015
66,298
$
663
$
522,873
$
99,332
$
14,838
$
116,277
$
753,983
Net income
-
-
-
12,106
-
3,304
15,410
Other comprehensive loss
-
-
-
-
(23,094
)
(2,200
)
(25,294
)
Sale of common stock through employee stock option and purchase plans
194
2
1,076
-
-
-
1,078
Restricted stock awards vesting and expense
15
-
268
-
-
-
268
Share-based compensation expense
-
-
680
-
-
-
680
Purchase of common stock of subsidiary
-
-
27
-
-
(105
)
(78
)
Balance at August 2, 2015
66,507
$
665
$
524,924
$
111,438
$
(8,256
)
$
117,276
$
746,047
Three Months Ended August 3, 2014
Photronics, Inc. Shareholders
Accumulated
Other
Comprehensive
Income
Common Stock
Additional
Paid-in
Capital
Retained
Earnings
Non-
controlling
Interests
Total
Equity
Shares
Amount
Balance at May 4, 2014
61,408
$
614
$
495,514
$
76,972
$
30,019
$
106,620
$
709,739
Net income
-
-
-
4,186
-
3,158
7,344
Other comprehensive income
-
-
-
-
1,575
545
2,120
Sale of common stock through employee
stock option and purchase plans
17
-
75
-
-
-
75
Restricted stock awards vesting and expense
27
1
307
-
-
-
308
Share-based compensation expense
-
-
675
-
-
-
675
Balance at August 3, 2014
61,452
$
615
$
496,571
$
81,158
$
31,594
$
110,323
$
720,261
10
Index
Nine Months Ended August 2, 2015
Photronics, Inc. Shareholders
Accumulated
Other
Comprehensive
Income (Loss)
Common Stock
Additional
Paid-in
Capital
Retained
Earnings
Non-
controlling
Interests
Total
Equity
Shares
Amount
Balance at November 2, 2014
65,930
$
659
$
520,183
$
85,435
$
21,774
$
111,443
$
739,494
Net income
-
-
-
26,003
-
8,706
34,709
Other comprehensive income
-
-
-
-
(30,030
)
(2,768
)
(32,798
)
Sale of common stock through employee
stock option and purchase plans
433
4
1,932
-
-
-
1,936
Restricted stock awards vesting and expense
144
2
800
-
-
-
802
Share-based compensation expense
-
-
1,982
-
-
-
1,982
Purchase of common stock of subsidiary
-
-
27
-
-
(105
)
(78
)
Balance at August 2, 2015
66,507
$
665
$
524,924
$
111,438
$
(8,256)
$
117,276
$
746,047
Nine Months Ended August 3, 2014
Photronics, Inc. Shareholders
Accumulated
Other
Comprehensive
Income
Common Stock
Additional
Paid-in
Capital
Retained
Earnings
Non-
controlling
Interests
Total
Equity
Shares
Amount
Balance at November 3, 2013
61,083
$
611
$
498,861
$
59,439
$
26,403
$
2,517
$
587,831
Net income
-
-
-
21,719
-
3,617
25,336
Other comprehensive income
-
-
-
-
4,792
498
5,290
Sale of common stock through employee stock option and purchase plans
213
2
765
-
-
-
767
Restricted stock awards vesting and expense
156
2
1,005
-
-
-
1,007
Share-based compensation expense
-
-
2,122
-
-
-
2,122
Acquisition of DPTT
-
-
(6,291
)
-
411
105,404
99,524
Redemption of common stock by subsidiary
-
-
109
-
(12
)
(1,713
)
(1,616
)
Balance at August 3, 2014
61,452
$
615
$
496,571
$
81,158
$
31,594
$
110,323
$
720,261
11
Index
NOTE 4 - PROPERTY, PLANT AND EQUIPMENT
Property, plant and equipment consists of the following:
August 2,
2015
November 2,
2014
Land
$
8,106
$
8,598
Buildings and improvements
121,696
124,787
Machinery and equipment
1,460,316
1,367,691
Leasehold improvements
19,671
20,165
Furniture, fixtures and office equipment
12,677
12,086
Construction in progress
15,538
81,351
1,638,004
1,614,678
Less accumulated depreciation and amortization
1,069,083
1,064,609
$
568,921
$
550,069
Equipment under capital leases are included in above property, plant and equipment as follows:
August 2,
2015
November 2,
2014
Machinery and equipment
$
56,245
$
56,245
Less accumulated amortization
14,648
10,430
$
41,597
$
45,815
Depreciation and amortization expense for property, plant and equipment was $19.4 million and $56.4 million for the three and nine month periods ended August 2, 2015, respectively, and $19.8 million and $52.9 million for the three and nine month periods ended August 3, 2014, respectively.
NOTE 5 - JOINT VENTURE, TECHNOLOGY LICENSE AND OTHER AGREEMENTS WITH MICRON TECHNOLOGY, INC.
In May 2006, Photronics and Micron Technology, Inc. ("Micron") entered into the MP Mask joint venture (“MP Mask”), which develops and produces photomasks for leading-edge and advanced next generation semiconductors. At the time of the formation of the joint venture, the Company also entered into both an agreement to license photomask technology developed by Micron and certain supply agreements.
This joint venture is a variable interest entity ("VIE") (as that term is defined in the ASC) because all costs of the joint venture are passed on to the Company and Micron through purchase agreements they have entered into with the joint venture, and it is dependent upon the Company and Micron for any additional cash requirements. On a quarterly basis the Company reassesses whether its interest in MP Mask gives it a controlling financial interest in this VIE. The purpose of this quarterly reassessment is to identify the primary beneficiary (which is defined in the ASC as the entity that consolidates a VIE) of the VIE. As a result of the reassessment in the current quarter, the Company determined that Micron is still the primary beneficiary of the VIE, by virtue of its tie-breaking voting rights within MP Mask’s Board of Managers, thereby giving it the power to direct the activities of MP Mask that most significantly impact its economic performance, including its decision making authority in the ordinary course of business and its purchasing the majority of products produced by the VIE.
The Company has utilized MP Mask for both high-end IC photomask production and research and development purposes. MP Mask charges its variable interest holders based on their actual usage of its facility. MP Mask separately charges for any research and development activities it engages in at the requests of its owners. The Company recorded cost of sales of $1.5 million and $4.9 million and research and development expenses of $0.2 million and $0.7 million during the three and nine month periods ended August 2, 2015. Cost of sales of $1.1 million and $3.0 million and research and development expenses of $0.2 million and $0.7 million were recorded during the three and nine month periods ended August 3, 2014. As of August 2, 2015 and November 2, 2014, the Company owed MP Mask $4.5 million and $4.2 million, respectively, and had a receivable from Micron of $10.1 million and $6.8 million, respectively, both primarily related to the aforementioned supply agreements.
12
Index
MP Mask is governed by a Board of Managers, appointed by Micron and the Company. Since MP Mask's inception, Micron, as a result of its majority ownership, has held majority voting power on the Board of Managers. The voting power held by each party is subject to change as ownership interests change. Under the MP Mask joint venture operating agreement, the Company may be required to make additional capital contributions to MP Mask up to the maximum amount defined in the operating agreement. However, should the Board of Managers determine that further additional funding is required, MP Mask shall pursue its own financing. If MP Mask is unable to obtain its own financing, it may request additional capital contributions from the Company. Should the Company choose not to make a requested contribution to MP Mask, its ownership percentage may be reduced.
The Company's investment in the VIE, which represents its maximum exposure to loss, was $93.0 million at August 2, 2015 and $93.1 million at November 2, 2014. These amounts are reported in the Company's condensed consolidated balance sheets as "Investment in joint venture." The Company did not realize a gain or a loss from its investment in the VIE in the three month period ended August 2, 2015, and realized a loss of $0.1 million from its investment in the VIE in the nine month period ended August 2, 2015. The Company recorded income of $0.1 million from its investment in the VIE in the three and nine month periods ended August 3, 2014.
On March 24, 2015, the Company announced that the MP Mask joint venture would not be renewed after May 5, 2016. The MP Mask operating agreement provides that Micron will make a payment to the Company to purchase the Company’s equity interest in MP Mask based on the Company’s ownership percentage of the net book value of MP Mask at that time, which, as of March 5, 2015, was approximately $93 million. The Company does not expect that it will incur a significant gain or loss on this transaction. Concurrently, the Company announced that it entered into supply and technology license agreements with Micron. This supply agreement, which commences on May 6, 2016, with a one-year term subject to mutually agreeable renewals, provides that the Company will be the majority outsource supplier of Micron’s photomasks and related services. This technology license agreement commenced in March 2015 and continues through the earlier of one year from the termination of the initial technology license agreement on May 5, 2016, or when Micron certifies that it has transferred certain defined technology to the Company. The Company forevermore has the rights to use the technology obtained under these technology license agreements.
NOTE 6 - LONG-TERM BORROWINGS
Long-term borrowings consist of the following:
August 2,
2015
November 2,
2014
3.25% convertible senior notes due in April 2016
$
57,500
$
115,000
3.25% convertible senior notes due in April 2019
57,500
-
2.77% capital lease obligation payable through July 2018
16,643
20,481
3.09% capital lease obligation payable through March 2016
3,391
6,705
135,034
142,186
Less current portion
16,577
10,381
$
118,457
$
131,805
The Company’s credit facility, which expires in December 2018, has a $50 million limit with an expansion capacity to $75 million, and is secured by substantially all of the Company’s assets located in the United States and common stock the Company owns in certain of its foreign subsidiaries. The credit facility is subject to a minimum interest coverage ratio, total leverage ratio and minimum unrestricted cash balance financial covenants, all of which the Company was in compliance with at August 2, 2015. The Company had no outstanding borrowings against the credit facility at August 2, 2015, and $50 million was available for borrowing. The interest rate on the credit facility (1.69% at August 2, 2015) is based on the Company’s total leverage ratio at LIBOR plus a spread, as defined in the credit facility.
13
Index
In January 2015 the Company privately exchanged $57.5 million in aggregate principal amount of its 3.25% convertible senior notes with a maturity date of April 1, 2016, for new 3.25% convertible senior notes with an aggregate principal amount of $57.5 million with a maturity date of April 1, 2019. The conversion rate of the new notes is the same as that of the exchanged notes, which were issued in March 2011 with a conversion rate of approximately 96 shares of common stock per $1,000 note principal, equivalent to a conversion price of $10.37 per share of common stock, and is subject to adjustment upon the occurrence of certain events, which are described in the indenture dated January 22, 2015. Note holders may convert each $1,000 principal amount of notes at any time prior to the close of business on the second scheduled trading day immediately preceding April 1, 2019, and the Company is not required to redeem the notes prior to their maturity date. Interest on the notes accrues in arrears, and is paid semiannually through the notes’ maturity date. The Company intends to repay $50 million of its outstanding 3.25% convertible senior notes due in April 2016 with borrowings against its credit facility and, therefore, has classified $50 million of these notes that were outstanding as of August 2, 2015, as long term.
In August 2013 a $26.4 million principal amount, five year capital lease commenced to fund the purchase of a high-end lithography tool. Payments under the capital lease, which bears interest at 2.77%, are $0.5 million per month through July 2018. Under the terms of the lease agreement, the Company must maintain the equipment in good working order, and is subject to a cross default with cross acceleration provision related to certain nonfinancial covenants incorporated in its credit facility. As of August 2, 2015, the total amount payable through the end of the lease term was $17.4 million, of which $16.6 million represented principal and $0.8 million represented interest.
In April 2011 the Company entered into a five year, $21.2 million capital lease for manufacturing equipment. Payments under the lease, which bears interest at 3.09%, are $0.4 million per month through March 2016. The lease agreement provides that the Company must maintain the equipment in good working order, and includes a cross default with cross acceleration provision related to certain non-financial covenants incorporated in the Company's credit facility agreement. As of August 2, 2015, the total amount payable through the end of the lease term, substantially all of which represented principal, was $3.4 million.
NOTE 7 - SHARE-BASED COMPENSATION
The Company has a share-based compensation plan ("Plan"), under which options, restricted stock, restricted stock units, stock appreciation rights, performance stock, performance units, and other awards based on, or related to, shares of the Company's common stock may be granted from shares authorized but unissued or shares previously issued and reacquired by the Company. The maximum number of shares of common stock approved by the Company’s shareholders to be issued under the Plan was increased from six million shares to nine million shares during fiscal year 2014. Awards may be granted to officers, employees, directors, consultants, advisors, and independent contractors of the Company or its subsidiaries. In the event of a change in control (as defined in the Plan), the vesting of awards may be accelerated. The Plan, aspects of which are more fully described below, prohibits further awards from being issued under prior plans. Total share-based compensation costs for the three and nine month periods ended August 2, 2015, were $0.9 million and $2.8 million, respectively, and $1.0 million and $3.1 million for the three and nine month periods ended August 3, 2014, respectively. The Company received cash from option exercises of $1.1 million and $2.1 million for the three and nine month periods ended August 2, 2015, respectively, and $0.1 million and $0.8 million for the three and nine month periods ended August 3, 2014, respectively. No share-based compensation cost was capitalized as part of an asset and no related income tax benefits were recorded during the periods presented.
Stock Options
Option awards generally vest in one to four years, and have a ten-year contractual term. All incentive and non-qualified stock option grants have an exercise price equal to the market value of the underlying common stock on the date of grant. The grant date fair values of options are based on closing prices of the Company’s common stock on the dates of grant using the Black-Scholes option pricing model. Expected volatility is based on the historical volatility of the Company's stock. The Company uses historical option exercise behavior and employee termination data to estimate expected term, which represents the period of time that the options granted are expected to remain outstanding. The risk-free rate of return for the estimated term of the option is based on the U.S. Treasury yield curve in effect at the date of grant.
14
Index
The weighted-average inputs and risk-free rate of return ranges used to calculate the grant date fair value of options issued during the three and nine month periods ended August 2, 2015 and August 3, 2014, are presented in the following table.
Three Months Ended
Nine Months Ended
August 2,
2015
August 3,
2014
August 2,
2015
August 3,
2014
Expected volatility
42.9%
58.1%
53.9%
61.0%
Risk free rate of return
1.4% – 1.6%
1.4%
1.3% - 1.6%
1.4%
Dividend yield
N/A
N/A
N/A
N/A
Expected term
4.7 years
4.6 years
4.7 years
4.6 years
Information on outstanding and exercisable option awards as of August 2, 2015, is presented below.
Options
Shares
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life
Aggregate
Intrinsic
Value
Outstanding at August 2, 2015
3,873,693
$
7.29
6.3 years
$
7,075
Exercisable at August 2, 2015
2,323,643
$
6.92
4.8 years
$
6,110
There were 63,000 share options granted during the three month period ended August 2, 2015,
with a weighted-average grant date fair value of $3.46 per share, and there were 20,000 share options granted during the three month period ended August 3, 2014, with a weighted-average grant date fair value of $4.24 per share. There were 667,800 share options granted during the nine month period ended August 2, 2015, with a weighted-average grant date fair value of $3.82 per share and 632,500 share options granted during the nine month period ended August 3, 2014, with a weighted-average grant date fair value of $4.44 per share. As of August 2, 2015, the total unrecognized compensation cost related to unvested option awards was approximately $4.5 million. That cost is expected to be recognized over a weighted-average amortization period of 2.5 years.
Restricted Stock
The Company periodically grants restricted stock awards. The restrictions on these awards typically lapse over a service period of less-than-one year to four years. 10,000 restricted stock awards were granted during the three month period ended August 2, 2015, with a weighted-average grant date fair value of $8.84 per share and 121,334 restricted stock awards were issued during the nine month period ended August 2, 2015, with a weighted-average grant date fair value of $8.28 per share. No restricted stock awards were granted during the three month period ended August 3, 2014, and 111,667 restricted stock awards were issued during the nine month period ended August 3, 2014, with a weighted-average grant date fair value of $8.86 per share. As of August 2, 2015, the total compensation cost not yet recognized related to unvested restricted stock awards was approximately $1.1 million. That cost is expected to be recognized over a weighted-average amortization period of 2.1 years. As of August 2, 2015, there were 212,776 shares of restricted stock outstanding.
NOTE 8 - INCOME TAXES
The effective tax rate differs from the U.S. statutory rate of 35% in the three and nine month periods ended August 2, 2015 and August 3, 2014, primarily due to earnings being taxed at lower statutory rates in foreign jurisdictions, the partial reversal of a deferred tax asset valuation allowance, and various investment credits in foreign jurisdictions. Valuation allowances in jurisdictions with historic losses eliminate the effective rate impact of these jurisdictions.
During the three month period ended May 3, 2015, the Company determined that deferred tax assets of $1.5 million, whose realization was previously not considered to be more likely than not, are realizable. Therefore, their related valuation allowances were reduced and the deferred tax assets were recognized. In the three month period ended August 2, 2015, $0.2 million of additional deferred tax assets were recognized.
15
Index
Unrecognized tax benefits related to uncertain tax positions were $5.6 million at August 2, 2015, and $5.1 million at November 2, 2014, of which $5.5 million and $5.0 million, respectively, would, if recognized, favorably impact the Company's effective tax rate. Accrued interest and penalties related to unrecognized tax benefits was $0.2 million at August 2, 2015, $0.1 million of which was recognized during the nine month period ended August 2, 2015. As of August 2, 2015, the total amount of unrecognized tax benefits is not expected to significantly increase or decrease in the next twelve months.
Due to changes in the operational structure of a foreign subsidiary and a related redemption of the subsidiary’s investment in shares of an affiliate, the Company has determined that, as of August 2, 2015, the historic and future accumulated earnings of that subsidiary were not required for future reinvestment. Accordingly, earnings of $127.2 million that were considered to be indefinitely reinvested at November 2, 2014, were reduced by $16.4 million, against which a $5.7 million deferred tax liability that is offset by fully valued loss carryforwards has been established.
PKLT, the Company's FPD manufacturing facility in Taiwan, has been accorded a tax holiday that started in 2012 and expires in 2017. The PKLT tax holiday had no dollar or per share effect on the financial results of the three or nine month periods ended August 2, 2015 and August 3, 2014. PDMC, as a result of the DPTT Acquisition, acquired an IC manufacturing facility in Taiwan that has been accorded a tax holiday that commenced in 2015 and expires in 2019. The Company realized $0.1 million and $0.2 million in tax benefits from the PDMC tax holiday for the three and nine month periods ended August 2, 2015, respectively, and no dollar benefit for the three and nine month periods ended August 3, 2014. The tax holiday had no per share effect on the financial results for the three or nine month periods ended August 2, 2015 and August 3, 2014.
NOTE 9 - EARNINGS PER SHARE
The calculation of basic and diluted earnings per share is presented below.
Three Months Ended
Nine Months Ended
August 2,
2015
August 3,
2014
August 2,
2015
August 3,
2014
Net income attributable to Photronics, Inc. shareholders
$
12,106
$
4,186
$
26,003
$
21,719
Effect of dilutive securities:
Interest expense on convertible notes, net of related tax effects
1,071
-
3,292
4,626
Earnings for diluted earnings per share
$
13,177
$
4,186
$
29,295
$
26,345
Weighted-average common shares computations:
Weighted-average common shares used for basic earnings per share
66,454
61,436
66,250
61,336
Effect of dilutive securities:
Convertible notes
11,085
-
11,085
15,423
Share-based payment awards
1,030
996
965
947
Potentially dilutive common shares
12,115
996
12,050
16,370
Weighted-average common shares used for diluted earnings per share
78,569
62,432
78,300
77,706
Basic earnings per share
$
0.18
$
0.07
$
0.39
$
0.35
Diluted earnings per share
$
0.17
$
0.07
$
0.37
$
0.34
16
Index
The table below shows the outstanding weighted-average share-based payment awards that were excluded from the calculation of diluted earnings per share because their exercise price exceeded the average market value of the common shares for the period, and convertible notes that, if converted, would have been antidilutive.
Three Months Ended
Nine Months Ended
August 2,
2015
August 3,
2014
August 2,
2015
August 3,
2014
Share-based payment awards
1,667
1,869
1,636
2,044
Convertible notes
-
15,423
-
-
Total potentially dilutive shares excluded
1,667
17,292
1,636
2,044
NOTE 10 - CHANGES IN ACCUMULATED OTHER COMPREHENSIVE INCOME BY COMPONENT
The following tables set forth the
changes in the Company's accumulated other comprehensive income by component (net of tax of $0)
for the three and nine month periods ended August 2, 2015 and August 3, 2014:
Three Months Ended August 2, 2015
Foreign Currency
Translation
Adjustments
Amortization
of Cash
Flow Hedge
Other
Total
Balance at May 3, 2015
$
15,648
$
(370
)
$
(440
)
$
14,838
Other comprehensive income (loss) before reclassifications
(25,342
)
-
16
(25,326
)
Amounts reclassified from other comprehensive income
-
32
-
32
Net current period other comprehensive income (loss)
(25,342
)
32
16
(25,294
)
Less: other comprehensive income (loss) attributable to noncontrolling interests
(2,208
)
-
8
(2,200
)
Balance at August 2, 2015
$
(7,486
)
$
(338
)
$
(432
)
$
(8,256
)
Three Months Ended August 3, 2014
Foreign Currency
Translation
Adjustments
Amortization
of Cash
Flow Hedge
Other
Total
Balance at May 4, 2014
$
30,928
$
(498
)
$
(411
)
$
30,019
Other comprehensive income before reclassifications
2,088
-
-
2,088
Amounts reclassified from other comprehensive income
-
32
-
32
Net current period other comprehensive income
2,088
32
-
2,120
Less: other comprehensive income attributable to noncontrolling interests
541
-
4
545
Balance at August 3, 2014
$
32,475
$
(466
)
$
(415
)
$
31,594
17
Index
Nine Months Ended August 2, 2015
Foreign Currency
Translation
Adjustments
Amortization
of Cash
Flow Hedge
Other
Total
Balance at November 2, 2014
$
22,651
$
(434
)
$
(443
)
$
21,774
Other comprehensive income (loss) before reclassifications
(32,915
)
-
21
(32,894
)
Amounts reclassified from other comprehensive income
-
96
-
96
Net current period other comprehensive income (loss)
(32,915
)
96
21
(32,798
)
Less: other comprehensive income (loss) attributable to noncontrolling interests
(2,778
)
-
10
(2,768
)
Balance at August 2, 2015
$
(7,486
)
$
(338
)
$
(432
)
$
(8,256
)
Nine Months Ended August 3, 2014
Foreign Currency
Translation
Adjustments
Amortization
of Cash
Flow Hedge
Other
Total
Balance at November 3, 2013
$
27,797
$
(562
)
$
(832
)
$
26,403
Other comprehensive income before reclassifications
5,176
-
18
5,194
Amounts reclassified from other comprehensive income
-
96
-
96
Net current period other comprehensive income
5,176
96
18
5,290
Less: other comprehensive income attributable to noncontrolling interests
498
-
-
498
Other comprehensive income allocated to noncontrolling interests
-
-
411
411
Redemption of common stock by subsidiary
-
-
(12
)
(12
)
Balance at August 3, 2014
$
32,475
$
(466
)
$
(415
)
$
31,594
The amortization of the cash flow hedge is included in cost of sales in the condensed consolidated statements of income for all periods presented.
NOTE 11 - FAIR VALUE MEASUREMENTS
The accounting framework for determining fair value includes a hierarchy for ranking the quality and reliability of the information used to measure fair value, which enables the reader of the financial statements to assess the inputs used to develop those measurements. The fair value hierarchy consists of three tiers as follows: Level 1, defined as quoted market prices in active markets for identical securities; Level 2, defined as inputs other than Level 1 that are observable, either directly or indirectly; and Level 3, defined as unobservable inputs that are not corroborated by market data.
The Company did not have any assets or liabilities measured at fair value on a recurring or nonrecurring basis at August 2, 2015 or November 2, 2014.
18
Index
Fair Value of Other Financial Instruments
The fair values of the Company's cash and cash equivalents (Level 1 measurements), accounts receivable, accounts payable, and certain other current assets and current liabilities (Level 2 measurements) approximate their carrying value due to their short-term maturities. The fair value of the Company’s convertible senior notes is a Level 2 measurement that is determined using recent bid prices.
The table below presents the fair and carrying values of the Company's convertible senior notes at August 2, 2015 and November 2, 2014.
August 2, 2015
November 2, 2014
Fair Value
Carrying Value
Fair Value
Carrying Value
3.25% convertible senior notes due 2016
$
59,329
$
57,500
$
122,544
$
115,000
3.25% convertible senior notes due 2019
$
60,835
$
57,500
$
-
$
-
NOTE 12 - SUBSIDIARY SHARE REPURCHASE
In June 2015 the Company increased its ownership interest in PKL, a subsidiary of the Company based in Korea, to 99.77% from 99.75%, by purchasing 15,000 shares of its common stock from noncontrolling interests at a cost of $0.1 million.
In January 2014 the Company increased its ownership percentage in PSMC, a subsidiary of the Company based in Taiwan, to 100% at a cost of $1.7 million for the then remaining 3.0 million shares that were not owned by the Company. In April 2014 DPTT merged into PSMC to form PDMC. See Note 2 for further discussion relating to this transaction.
The table below presents the effect of the change in the Company’s ownership interest in its subsidiaries on the Company's equity for the three and nine month periods ended August 2, 2015 (15 thousand shares of common stock acquired), and the nine month period ended August 3, 2014, (3.0 million shares of common stock acquired and 112.9 million shares of common stock issued). The Company’s ownership interest in its subsidiaries did not change during the three month period ended August 3, 2014.
Three Months Ended
Nine Months Ended
August 2,
2015
August 3,
2014
August 2,
2015
August 3,
2014
Net income attributable to Photronics, Inc. shareholders
$
12,106
$
4,186
$
26,003
$
21,719
Increase (decrease) in Photronics, Inc.'s additional paid-in capital
27
-
27
(6,182
)
Increase in Photronics, Inc. shareholders’ accumulated other comprehensive income
-
-
-
399
Change from net income attributable to Photronics, Inc. shareholders and transfer from noncontrolling interest
$
12,133
$
4,186
$
26,030
$
15,936
NOTE 13 - COMMITMENTS AND CONTINGENCIES
As of August 2, 2015, the Company had commitments outstanding for capital expenditures of approximately $3 million.
The Company is subject to various claims that arise in the ordinary course of business. The Company believes such claims, individually or in the aggregate, will not have a material effect on its condensed consolidated financial statements.
19
Index
NOTE 14 - RECENT ACCOUNTING PRONOUNCEMENTS
In April 2015 the FASB issued ASU 2015-03 – “Simplifying the Presentation of Debt Issuance Costs.” This update requires debt issuance costs related to a recognized debt liability to be presented in the balance sheet as a direct deduction from that debt liability, consistent with the presentation of a debt discount. This ASU will be effective for the Company in its first quarter of fiscal 2017. Upon adoption, all prior periods presented should be restated to reflect the amendments in this update. Early adoption is permitted. The Company is currently evaluating the effect of this ASU on its consolidated financial statements.
In May 2014 the FASB issued ASU 2014-09 – “Revenue from Contracts with Customers,” which will supersede nearly all existing revenue recognition guidance under U.S. GAAP. The core principle of this ASU is that revenue should be recognized for the amount of consideration expected to be received for promised goods or services transferred to customers. This ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments, and assets recognized for costs incurred to obtain or fulfill a contract. ASU 2014-09 allows for either full retrospective or modified retrospective adoption. In August 2015 the FASB issued ASU 2015-14 “Deferral of the Effective date,” which defers the required adoption date of ASU 2014-09 by one year. As a result of the deferred effective date, ASU 2014-09 will be effective for the Company in its first quarter of fiscal 2019. Early adoption is permitted but not before the Company’s original effective date of its first quarter of fiscal 2018. The Company is evaluating the transition method that will be elected and the potential effects of the adoption of this ASU on its financial statements.
Item 2.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Overview
Management's discussion and analysis ("MD&A") of the Company's financial condition, results of operations and outlook should be read in conjunction with its condensed consolidated financial statements and related notes. Various segments of this MD&A contain forward-looking statements, all of which are presented based on current expectations and may be adversely affected by uncertainties and risk factors (presented throughout this filing and in the Company's Annual Report on Form 10-K for the fiscal 2014 year), that may cause actual results to materially differ from these expectations.
On April 4, 2014, DNP Photomask Technology Taiwan Co., Ltd. (“DPTT”), a wholly owned subsidiary of Dai Nippon Printing Co., Ltd. (“DNP”), merged into Photronics Semiconductor Mask Corporation (“PSMC”), a wholly owned subsidiary of Photronics. All of the assets and liabilities of DPTT existing prior to the merger were assumed by the renamed surviving entity of the merger, Photronics DNP Mask Corporation (“PDMC”). Photronics and DNP own 50.01 percent and 49.99 percent of PDMC, respectively, and the results of DPTT are included in the condensed consolidated financial statements since the date of the acquisition.
Throughout this report the merger of DPTT into PSMC is referred to as the “DPTT Acquisition.”
The Company sells substantially all of its photomasks to semiconductor designers and manufacturers, and manufacturers of FPDs. Photomask technology is also being applied to the fabrication of other higher performance electronic products such as photonics, micro-electronic mechanical systems and certain nanotechnology applications. Thus, the Company's selling cycle is tightly interwoven with the development and release of new semiconductor designs and flat panel applications, particularly as it relates to the semiconductor industry's migration to more advanced design methodologies and fabrication processes. The Company believes that the demand for photomasks primarily depends on design activity rather than sales volumes from products produced using photomask technologies. Consequently, an increase in semiconductor or FPD sales does not necessarily result in a corresponding increase in photomask sales. However, the reduced use of customized ICs, reductions in design complexity, other changes in the technology or methods of manufacturing or designing semiconductors, or a slowdown in the introduction of new semiconductor or FPD designs could reduce demand for photomasks even if demand for semiconductors and FPDs increases. Advances in semiconductor, FPD and photomask design and semiconductor production methods could also reduce the demand for photomasks. Historically, the semiconductor industry has been volatile, with sharp periodic downturns and slowdowns. These downturns have been characterized by, among other things, diminished product demand, excess production capacity and accelerated erosion of selling prices.
The global semiconductor industry, including mobile displays, is driven by end markets which have been closely tied to consumer driven applications of high performance semiconductor devices including, but not limited to, mobile communications and computing solutions. The Company is typically required to fulfill its customer orders within a short period of time, sometimes within 24 hours. This results in the Company having a minimal level of backlog orders, typically one to two weeks for IC photomasks and two to three weeks for FPD photomasks. The Company cannot predict the timing of the industry's transition to volume production of next generation technology nodes or the timing of up and down cycles with precise accuracy, but believes that such transitions and cycles will continue into the future, beneficially and adversely affecting its business, financial condition and operating results in the near term. The Company believes its ability to remain successful in these environments is dependent upon achieving its goals of being a service and technology leader and efficient solutions supplier, which it believes should enable it to continually reinvest in its global infrastructure.
20
Index
Material Changes in Results of Operations
Three and Nine Months ended August 2, 2015 and August 3, 2014
The following table represents selected operating information expressed as a percentage of net sales.
Three Months Ended
Nine Months Ended
August 2, 2015
August 3, 2014
August 2, 2015
August 3, 2014
Net sales
100.0
%
100.0
%
100.0
%
100.0
%
Cost of sales
(71.7
)
(77.1
)
(74.2
)
(77.7
)
Gross margin
28.3
22.9
25.8
22.3
Selling, general and administrative expenses
(9.4
)
(9.9
)
(9.6
)
(11.5
)
Research and development expenses
(4.8
)
(4.1
)
(4.4
)
(4.9
)
Operating income
14.1
8.9
11.8
5.9
Gain on acquisition
-
-
-
4.9
Other income (expense), net
0.2
(1.0
)
(0.7
)
(1.0
)
Income before income tax provision
14.3
7.9
11.1
9.8
Income tax provision
(2.6
)
(2.0
)
(2.0
)
(2.2
)
Net income
11.7
5.9
9.1
7.6
Net income attributable to noncontrolling interests
(2.5
)
(2.5
)
(2.3
)
(1.0
)
Net income attributable to Photronics, Inc. shareholders
9.2
%
3.4
%
6.8
%
6.6
%
Note: All of the following tabular comparisons, unless otherwise indicated, are for the three months ended August 2, 2015 (Q3-15) and August 3, 2014 (Q3-14) and for the nine months ended August 2, 2015 (YTD-15) and August 3, 2014 (YTD-14), in millions of dollars.
Net Sales
Three Months Ended
Nine Months Ended
Q3-15
Q3-14
Percent
Change
YTD-15
YTD-14
Percent
Change
IC
$
104.0
$
100.6
3.4
%
$
309.3
$
253.4
22.1
%
FPD
27.7
24.3
14.1
%
73.2
77.9
(6.1
)%
Total net sales
$
131.7
$
124.9
5.5
%
$
382.5
$
331.3
15.5
%
Net sales for Q3-15 increased 5.5% to $131.7 million as compared to $124.9 million for Q3-14. The increase was primarily a result of increased high-end sales of both IC and FPD photomasks. Revenues attributable to high-end products increased by $5.4 million to $57.0 million in Q3-15 as compared to $51.6 million in Q3-14. High-end photomask applications include mask sets for 45 nanometer and below for IC products, and G8 and above and active matrix organic light-emitting diode (AMOLED) display screen technologies for FPD products. By geographic area, net sales in Q3-15, as compared to Q3-14, increased (decreased) by $(1.8) million or (3.5)% to $50.5 million in Taiwan, $4.4 million or 13.1% to $37.6 million in Korea, $5.4 million or 19.1% to $33.8 million in the United States, and $(0.8) million or (8.4)%
to $9.1 million in Europe.
21
Index
Net sales for YTD-15 increased to $382.5 million as compared to $331.3 million for YTD-14 principally associated with the acquisition of DPTT in Taiwan as discussed in Note 2 to the condensed consolidated financial statements, and to a lesser extent, increased sales in the United States. Revenues attributable to high-end products increased by $43.8 million to $165.4 million in YTD-15 as compared to $121.6 million in YTD-14, primarily due to increased high-end IC sales in Taiwan, which was partially offset by lower high-end FPD sales.
The Company’s quarterly revenues can be affected by the seasonal purchasing of its customers. Demand for the Company's products is typically negatively impacted during the first six months of its fiscal year by the North American, European and Asian holiday periods, as some customers reduce their effective workdays and orders during this period.
Gross Margin
Three Months Ended
Nine Months Ended
Q3-15
Q3-14
Percent
Change
YTD-15
YTD-14
Percent
Change
Gross margin
$
37.2
$
28.7
30.0
%
$
98.5
$
73.7
33.6
%
Percentage of net sales
28.3
%
22.9
%
25.8
%
22.3
%
Gross margin percentage increased to 28.3% in Q3-15 from 22.9% in Q3-14 primarily due to increased sales and improved manufacturing efficiencies. The gross margin percentage increased to 25.8% in YTD-15 from 22.3% in YTD-14 primarily due to increased sales. The Company operates in a high fixed cost environment and, to the extent that the Company's revenues and utilization increase or decrease, gross margin will generally be positively or negatively impacted.
Selling, General and Administrative Expenses
Three Months Ended
Nine Months Ended
Q3-15
Q3-14
Percent
Change
YTD-15
YTD-14
Percent
Change
Selling, general and administrative expenses
$
12.4
$
12.4
-
%
$
36.8
$
38.1
(3.4
)%
Percentage of net sales
9.4
%
9.9
%
9.6
%
11.5
%
Selling, general and administrative expenses were $12.4 million in Q3-15 and Q3-14, and were $36.8 million in YTD-15 and $38.1 million in YTD-14. The year-to-date decrease was primarily the result of expenses related to the acquisition of DPTT of $2.5 million in YTD-14 as discussed in Note 2 to the condensed consolidated financial statements.
Research and Development
Three Months Ended
Nine Months Ended
Q3-15
Q3-14
Percent
Change
YTD-15
YTD-14
Percent
Change
Research and development
$
6.3
$
5.2
20.3
%
$
16.7
$
16.1
3.9
%
Percentage of net sales
4.8
%
4.1
%
4.4
%
4.9
%
Research and development expenses consist primarily of global development efforts related to high-end process technologies for advanced sub-wavelength reticle solutions for IC technologies. Research and development expenses increased by $1.1 million to $6.3 million in Q3-15, as compared to $5.2 million in Q3-14, and by $0.6 million to $16.7 million in YTD-15, as compared to $16.1 million in YTD-14. The increased research and development expenses in Q3-15 and YTD-15 as compared to the same periods in the prior year were primarily due to increased activities at advanced nanometer technology nodes for IC photomasks.
22
Index
Other Income (Expense), net
Three Months Ended
Nine Months Ended
Q3-15
Q3-14
YTD-15
YTD-14
Gain on acquisition
$
-
$
-
$
-
$
16.4
Interest expense
(1.2
)
(1.8
)
(3.8
)
(5.6
)
Interest and other income (expense), net
1.4
0.6
1.3
2.3
Other income (expense), net
$
0.2
$
(1.2
)
$
(2.5
)
$
13.1
In April 2014 DNP Photomask Technology Taiwan Co., Ltd., a wholly owned subsidiary of Dai Nippon Printing Co., Ltd. (DNP), merged into PSMC and operates under the name of Photronics DNP Mask Corporation (PDMC). The acquisition resulted in the Company recording a gain of $16.4 million in the second quarter of fiscal 2014. See Note 2 of the condensed consolidated financial statements for more information.
Interest expense decreased by $0.6 million in Q3-15, as compared to Q3-14, and by $1.8 million in YTD-15, as compared to YTD-14, primarily as a result of reduced outstanding borrowing balances.
Interest and other income (expense), net, increased in Q3-15 as compared to Q3-14 by $0.8 million primarily as a result of increased foreign currency gains offset in part by reduced interest income. Interest and other income, net, decreased by $1.0 million in YTD-15, as compared to YTD-14, primarily as a result of financing expenses related to the Company’s exchange of convertible debt in Q1-15 and reduced interest income, which were offset in part by increased foreign currency gains.
Income Tax Provision
Three Months Ended
Nine Months Ended
Q3-15
Q3-14
YTD-15
YTD-14
Income tax provision
$
3.4
$
2.5
$
7.8
$
7.3
Effective income tax rate
18.0
%
25.7
%
18.3
%
22.3
%
The Company’s effective income tax rate is sensitive to its jurisdictional mix of earnings, due in part to the non-recognition of tax benefits on losses in jurisdictions in which the Company has established valuation allowances for such benefits.
The effective income tax rate decrease in Q3-15, as compared with Q3-14, was primarily attributable to a greater percentage of income before income taxes being earned in jurisdictions where the Company maintains valuation allowances and, therefore, does not recognize a tax expense or benefit. The effective income tax rate decrease in YTD-15, as compared with YTD-14, was primarily attributable to a reduction in fiscal year 2015 of a deferred tax asset valuation allowance and a greater percentage of income before income taxes being earned in jurisdictions where the Company maintains valuation allowances, while in fiscal year 2014 a non-taxable gain related to the DPTT Acquisition was offset by a lower percentage of income before income taxes being earned in jurisdictions in which the Company maintains valuation allowances (and, therefore, does not recognize a tax expense or benefit).
As of each reporting date, the Company considers new evidence, both positive and negative, that could impact management’s views with regards to the future realization of deferred tax assets. In Q2-15, the Company determined that sufficient positive evidence existed in a foreign jurisdiction that it was more likely than not that additional deferred taxes of $1.5 million were realizable and, therefore, reduced the valuation allowance accordingly.
Net Income Attributable to Noncontrolling Interests
Net income attributable to noncontrolling interests increased $0.1 million to $3.3 million in Q3-15, as compared to $3.2 million in Q3-14, and by $5.1 million to $8.7 million in YTD-15, as compared to $3.6 million in YTD-14, primarily as a result of changes in the ownership structure of the Company’s IC manufacturing facility located in Taiwan. During Q2-14, the Company exchanged a 49.99% noncontrolling interest in PDMC, the Company’s IC manufacturing subsidiary in Taiwan, in return for the net assets of an acquiree. See Notes 2 and 12 of the condensed consolidated financial statements for further information.
23
Index
Liquidity and Capital Resources
The Company's working capital was $179.0 million at August 2, 2015, and $197.4 million at November 2, 2014. The decrease in working capital was primarily related to planned capital equipment purchases. Cash and cash equivalents were $191.6 million at August 2, 2015, and $192.9 million at November 2, 2014. Net cash provided by operating activities was $91.8 million for the nine month period ended August 2, 2015, as compared to $61.8 million for the nine month period ended August 3, 2014, the increase primarily due to increased income in 2015, as well as net income in 2014 included a $16.4 million noncash acquisition gain as discussed in Note 2 to the condensed consolidated financial statements. Net cash used in investing activities for the nine month period ended August 2, 2015, was $80.4 million, which was comprised primarily of capital expenditure payments. Net cash used in financing activities of $4.9 million for the nine month period ended August 2, 2015, was primarily comprised of repayments of long-term borrowings, offset in part by proceeds received from share-based arrangements. The Company may use its cash available on hand for operations, capital expenditures, debt repayments, strategic opportunities, stock repurchases or other corporate uses, any of which may be material.
On March 24, 2015, the Company announced that the MP Mask joint venture would not be renewed after May 5, 2016. The MP Mask operating agreement provides that Micron will make a payment to the Company to purchase the Company’s equity interest in MP Mask based on the Company’s ownership percentage of the net book value of MP Mask at that time, which, as of March 5, 2015, was approximately $93 million.
As of
August 2, 2015, and
November 2, 2014, the Company’s total cash and cash equivalents include $88.1 million and $105.9 million, respectively, held by its foreign subsidiaries. A repatriation of these funds to the U.S., in certain jurisdictions, may be subject to U.S. federal income and local country withholding taxes. The majority of earnings of the Company’s foreign subsidiaries are considered to be indefinitely reinvested. The Company’s foreign subsidiaries continue to grow through the reinvestment of earnings in additional manufacturing capacity and capability, particularly in the high-end IC and FPD areas.
In January 2015 the Company privately exchanged $57.5 million in aggregate principal amount of its 3.25% convertible senior notes with a maturity date of April 1, 2016, for new 3.25% convertible senior notes with an aggregate principal amount of $57.5 million with a maturity date of April 1, 2019. The conversion rate of the new notes is the same as that of the exchanged notes, which were issued in March 2011 with a conversion rate of approximately 96 shares of common stock per $1,000 note principal, equivalent to a conversion price of $10.37 per share of common stock, and is subject to adjustment upon the occurrence of certain events, which are described in the indenture dated January 22, 2015. Note holders may convert each $1,000 principal amount of notes at any time prior to the close of business on the second scheduled trading day immediately preceding April 1, 2019, and the Company is not required to redeem the notes prior to their maturity date. Interest on the notes accrues in arrears, and is paid semiannually through the notes’ maturity date. The Company intends to repay $50 million of its outstanding 3.25% convertible senior notes due in April 2016 with borrowings against its credit facility and, therefore, has classified $50 million of these notes that were outstanding as of August 2, 2015, as long term.
In April 2014 the Company acquired DPTT, which was a non-cash transaction that resulted in the Company owning 50.01% and DNP owning 49.99% of PDMC, whose financial results are included in the Company’s consolidated financial statements. PDMC has generated, and is expected to continue to generate, sufficient cash flows to fund its operating and capital requirements. See Note 2 of the consolidated financial statements for more information.
The Company’s credit facility, which expires in December 2018, has a $50 million limit with an expansion capacity to $75 million, and is secured by substantially all of the Company’s assets located in the United States and common stock the Company owns in certain of its foreign subsidiaries. The credit facility is subject to a minimum interest coverage ratio, total leverage ratio and minimum unrestricted cash balance financial covenants, all of which the Company was in compliance with at August 2, 2015. The Company had no outstanding borrowings against the credit facility at August 2, 2015, and $50 million was available for borrowing. The interest rate on the credit facility (1.69% at August 2, 2015) is based on the Company’s total leverage ratio at LIBOR plus a spread, as defined in the credit facility.
In January 2014 the Company acquired all of the 3.0 million shares of PSMC that were then held by noncontrolling interests at a cost of $1.7 million.
As of
August 2, 2015
, the Company had capital equipment commitments outstanding of approximately $3 million. The Company believes that its currently available resources, together with its capacity for growth, and its access to equity and other financing sources, will be sufficient to satisfy its currently planned capital expenditures, as well as its anticipated working capital requirements for the next twelve months. However, the Company cannot assure that additional sources of financing would be available to the Company on commercially favorable terms should the Company's capital requirements exceed cash available from operations, existing cash, and cash available under its credit facility.
24
Index
The Company's liquidity is highly dependent on its sales volume, cash conversion cycle, and the timing of its capital expenditures (which can vary significantly from period to period), as it operates in a high fixed cost environment. Depending on conditions in the semiconductor and FPD markets, the Company's cash flows from operations and current holdings of cash may not be adequate to meet its current and long-term needs for capital expenditures, operations and debt repayments. However, the Company believes its cash on hand, cash generated from its operations and cash committed under its credit facility will allow it to fund its operations through at least the next twelve months. Historically, in certain years, the Company has used external financing to fund these needs. Due to conditions in the credit markets, some financing instruments used by the Company in the past may not be currently available to it. The Company continues to evaluate further cost reduction initiatives. However, the Company cannot assure that additional sources of financing would be available to it on commercially favorable terms, should its cash requirements exceed cash available from operations, existing cash, and cash available under its credit facility.
Off-Balance Sheet Arrangements
Under the MP Mask joint venture operating agreement, in order to maintain its 49.99% ownership interest, the Company may be required to make additional capital contributions to the joint venture up to the maximum amount specified in the operating agreement. Cumulatively through August 2, 2015, the Company has contributed $32.5 million to the joint venture and has received distributions from the joint venture totaling $10.0 million.
On March 24, 2015, the Company announced that the MP Mask joint venture would not be renewed after May 5, 2016.
Under the PDMC operating agreement, the shareholders of PDMC may be requested to make additional contributions to PDMC. In the event that PDMC requests additional capital from its shareholders, the Company may be required to make additional capital contributions to PDMC in order to maintain its 50.01% ownership. The PDMC operating agreement limits the amount of contributions that may be requested during both the first four years of PDMC and during any individual year within those first four years. As of August 2, 2015, the Company has not been requested nor made any additional capital contributions to PDMC.
The Company leases certain office facilities and equipment under operating leases that may require it to pay taxes, insurance and maintenance expenses related to the properties. Certain of these leases contain renewal or purchase options exercisable at the end of the lease terms.
Business Outlook
A majority of the Company's revenue growth is expected to continue to come from the Asian region, as customers increase their use of manufacturing foundries located outside of North America and Europe. Additional revenue growth is also anticipated in North America, as the Company expects to continue to benefit from advanced technology it may utilize under its technology licenses with Micron.
The Company continues to assess its global manufacturing strategy and monitor its market capitalization, sales volume and related cash flows from operations. This ongoing assessment could result in future facility closures, asset redeployments, additional impairments of intangible or long-lived assets, workforce reductions, or the addition of increased manufacturing facilities, all of which would be based on market conditions and customer requirements.
Effect of Recent Accounting Pronouncements
See “Note 14 – Recent Accounting Pronouncements” to the condensed consolidated financial statements.
ITEM 3.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Foreign Currency Exchange Rate Risk
The Company conducts business in several major international currencies through its worldwide operations and its financial performance may be affected by fluctuations in the exchange rates of these currencies. Changes in exchange rates can positively or negatively affect the Company's sales, operating margins, assets, liabilities, and equity. The functional currencies of the Company's Asian subsidiaries are the Korean won, the New Taiwan dollar, and the Singapore dollar. The functional currencies of the Company's European subsidiaries are the British pound and the euro.
The Company attempts to minimize its risk of foreign currency transaction losses by producing its products in the same country in which the products are sold (thereby generating revenues and incurring expenses in the same currency), and by managing its working capital. However, in some instances, the Company sells products in a currency other than the functional currency of the country where it was produced or purchases products in a currency that differs from the functional currency of the purchasing manufacturing facility. There can be no assurance that this approach will continue to be successful, especially in the event of a significant adverse movement in the value of any foreign currency against the U.S. dollar, the New Taiwan dollar or the Korean won.
The Company's primary net foreign currency exposures as of August 2, 2015, included the Korean won, the Japanese yen, the New Taiwan dollar, the Singapore dollar, the British pound, and the euro. As of August 2, 2015, a 10% adverse movement in the value of these currencies against the U.S. dollar would have resulted in a net unrealized pre-tax loss of $4.2 million. The Company does not believe that a 10% change in the exchange rates of other non-U.S. dollar currencies would have a material effect on its consolidated financial position, results of operations, or cash flows.
25
Index
Interest Rate Risk
At August 2, 2015, the Company did not have any variable rate borrowings. A 10% change in interest rates would not have had a material effect on the Company’s consolidated financial position, results of operations, or cash flows in the three or nine month periods ended August 2, 2015.
Item 4.
CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
The Company has established and currently maintains disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), designed to provide reasonable assurance that information required to be disclosed in its reports filed under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms, and that such information is accumulated and communicated to management, including the Company's chief executive officer and chief financial officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
The Company's management, under the supervision and with the participation of the Company’s chief executive officer and chief financial officer, evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of the end of the period covered by this report. Based upon that evaluation the Company’s chief executive officer and chief financial officer concluded that the Company’s disclosure controls and procedures were effective at a reasonable assurance level as of the end of the period covered by this report.
Changes in Internal Control over Financial Reporting
There was no change in the Company's internal control over financial reporting during the Company's third quarter of fiscal 2015 that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting.
PART II. OTHER INFORMATION
Item 1A.
RISK FACTORS
There have been no material changes to risks relating to the Company's business as disclosed in Part 1, Item 1A of the Company's Form 10-K for the year ended November 2, 2014
.
26
Index
Item 6.
EXHIBITS
(a)
Exhibits
Exhibit
Number
Description
10.28
Executive Employment Agreement between the Company and Peter Kirlin dated May 4, 2015.
10.31
Executive Employment Agreement between the Company and Constantine Macricostas dated May 4, 2015.
31.1
Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2
Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2
Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS
XBRL Instance Document
101.SCH
XBRL Taxonomy Extension Schema Document
101.CAL
XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF
XBRL Taxonomy Extension Definition Linkbase Document
101.LAB
XBRL Taxonomy Extension Label Linkbase Document
101.PRE
XBRL Taxonomy Extension Presentation Linkbase Document
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Photronics, Inc.
(Registrant)
By:
/s/ SEAN T. SMITH
Sean T. Smith
Senior Vice President
Chief Financial Officer
(Duly Authorized Officer and
Principal Financial Officer)
Date: September 9, 2015
27